Safety, Pharmacokinetics, and Pharmacodynamics of BMS-986142, a Novel Reversible BTK Inhibitor, in Healthy Participants

European Journal of Clinical Pharmacology - Germany
doi 10.1007/s00228-017-2226-2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Safety, Pharmacokinetics and Pharmacodynamics of Hetrombopag Olamine, a Novel TPO-R Agonist, in Healthy Individuals

Basic and Clinical Pharmacology and Toxicology
MedicineToxicologyPharmacology
2017English

Pharmacokinetics and Pharmacodynamics of a Novel Acetylcholinesterase Inhibitor, DMNG-3

Acta Neurobiologiae Experimentalis
MedicineNeuroscience
2016English

Safety, Pharmacokinetics, and Pharmacodynamics of the Autotaxin Inhibitor GLPG1690 in Healthy Subjects: Phase 1 Randomized Trials

Journal of Clinical Pharmacology
Pharmacology
2019English

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of Empagliflozin, a Sodium Glucose Cotransporter 2 (SGLT2) Inhibitor, in Healthy Japanese Subjects

Drug Metabolism and Pharmacokinetics
PharmacologyPharmaceutical Science
2013English

Pharmacokinetics, Pharmacodynamics, and Safety of Peficitinib (ASP015K) in Healthy Male Caucasian and Japanese Subjects

Clinical Drug Investigation
MedicinePharmacology
2020English

Pharmacokinetics/Pharmacodynamics of Vaborbactam, a Novel Beta-Lactamase Inhibitor, in Combination With Meropenem

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2018English

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of E3024, a Novel and Selective Dipeptidyl Peptidase-Iv Inhibitor, in Healthy Japanese Male Subjects: Rash Development in Men and Its Possible Mechanism

Pharmacology & Pharmacy
2013English

Pharmacokinetics, Pharmacodynamics, Tolerability and Safety of Single Doses of Bivalirudin in Healthy Chinese Subjects

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2011English

Steady-State Pharmacokinetics and Pharmacodynamics of CHF3381, a Novel Antineuropathic Pain Agent, in Healthy Subjects

British Journal of Clinical Pharmacology
Pharmacology
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy